Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Steadifer
- Development stage
- Unknown
- Lead developer
- Steadfast Medishield
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Steadifer is an oral iron supplement containing ferrous fumarate, developed and marketed by Steadfast Medishield for the management of iron deficiency anemia, particularly in patients with chronic kidney disease (CKD). As a source of elemental iron, Steadifer facilitates the production of hemoglobin, which is often deficient in renal patients due to reduced erythropoietin production and impaired iron homeostasis. The product is part of a specialized renal care portfolio designed to address the hematological complications associated with kidney failure and organ transplantation.
- Brand names
- Steadifer
- Other names
- ferrous fumarate
Beyond the preview
Go deeper on Steadifer.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Steadifer.